0001375151-21-000021.txt : 20210317 0001375151-21-000021.hdr.sgml : 20210317 20210317160304 ACCESSION NUMBER: 0001375151-21-000021 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210315 FILED AS OF DATE: 20210317 DATE AS OF CHANGE: 20210317 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FARR STEPHEN J CENTRAL INDEX KEY: 0001247666 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34962 FILM NUMBER: 21750537 MAIL ADDRESS: STREET 1: SFARR@ZOGENIX.COM CITY: EMERYVILLE STATE: CA ZIP: 94608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ZOGENIX, INC. CENTRAL INDEX KEY: 0001375151 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 205300780 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5959 HORTON STREET, SUITE 500 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: (510) 550-8300 MAIL ADDRESS: STREET 1: 5959 HORTON STREET, SUITE 500 CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: ZOGENIX INC DATE OF NAME CHANGE: 20060911 4 1 wf-form4_161601134470951.xml FORM 4 X0306 4 2021-03-15 0 0001375151 ZOGENIX, INC. ZGNX 0001247666 FARR STEPHEN J C/O ZOGENIX, INC. 5959 HORTON STREET, SUITE 500 EMERYVILLE CA 94608 1 1 0 0 President and CEO Common Stock 2021-03-15 4 M 0 5000 0 A 84795 D Common Stock 2021-03-15 4 F 0 1729 20.70 D 83066 D Common Stock 2021-03-15 4 M 0 5000 0 A 88066 D Common Stock 2021-03-15 4 F 0 1729 20.70 D 86337 D Common Stock 2021-03-15 4 M 0 6875 0 A 93212 D Common Stock 2021-03-15 4 F 0 2378 20.70 D 90834 D Restricted Stock Units 2021-03-15 4 M 0 5000 0 D Common Stock 5000.0 5000 D Restricted Stock Units 2021-03-15 4 M 0 5000 0 D Common Stock 5000.0 15000 D Restricted Stock Units 2021-03-15 4 M 0 6875 0 D Common Stock 6875.0 20625 D Represents vesting of one-fourth (1/4) of restricted stock units granted on March 15, 2018. Includes 75 shares acquired under the Company's Employee Stock Purchase Plan since the last Section 16 filing by the Reporting Person. Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock units described in footnote 1. Represents vesting of one-fourth (1/4) of restricted stock units granted on March 22, 2019. Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock units described in footnote 3. Represents vesting of one-fourth (1/4) of restricted stock units granted on March 4, 2020. Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock units described in footnote 6. Each restricted stock unit represents a contingent right to receive one share of Zogenix common stock. The restricted stock units vests in four equal installments on each of March 15, 2019, 2020, 2021 and 2022, subject to the reporting person's continuous service to the Company on such vesting date. Not applicable. The restricted stock units vest in four equal installments on each of March 15, 2020, 2021, 2022 and 2023, subject to the reporting person's continuous service to the Company on such vesting date. The restricted stock units vests in four equal installments on each of March 15, 2021, 2022, 2023 and 2024, subject to the reporting person's continuous service to the Company on such vesting date. /s/ Thomas Doyle, Attorney-in-fact for Stephen Farr 2021-03-17